Redentor M. Pasia

Array ( [id] => 9046676 [patent_doc_number] => 08541229 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => 'Plasmids and phages for homologous recombination and methods of use' [patent_app_type] => utility [patent_app_number] => 12/688764 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 66 [patent_no_of_words] => 25163 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12688764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586355 [patent_doc_number] => 20110280865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Ets-2 Biomarkers for Fibrotic Diseases and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/144578 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7743 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280865.pdf [firstpage_image] =>[orig_patent_app_number] => 13144578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6447450 [patent_doc_number] => 20100144838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Methods for Identifying Modulators of Pyrimidine Tract Binding Protein' [patent_app_type] => utility [patent_app_number] => 12/628808 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13388 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144838.pdf [firstpage_image] =>[orig_patent_app_number] => 12628808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669561 [patent_doc_number] => 20110318830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'COMPOSITIONS AND METHODS FOR RE-PROGRAMMING AND RE-DIFFERENTIATING CELLS' [patent_app_type] => utility [patent_app_number] => 13/126703 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22087 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6595076 [patent_doc_number] => 20100062448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'PROTEIN KINASE C ZETA AS A DRUG TARGET FOR ARTHRITIS AND OTHER INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 12/616484 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9751 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062448.pdf [firstpage_image] =>[orig_patent_app_number] => 12616484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7500591 [patent_doc_number] => 20110263028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'MEGANUCLEASE RECOMBINATION SYSTEM' [patent_app_type] => utility [patent_app_number] => 13/125193 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 16344 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263028.pdf [firstpage_image] =>[orig_patent_app_number] => 13125193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18964408 [patent_doc_number] => 11898160 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-13 [patent_title] => Method for maintaining pluripotency in cells [patent_app_type] => utility [patent_app_number] => 12/577103 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 10099 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12577103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6372576 [patent_doc_number] => 20100080778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'STEM CELL EXPANSION ENHANCING FACTOR AND METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 12/573489 [patent_app_country] => US [patent_app_date] => 2009-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15705 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080778.pdf [firstpage_image] =>[orig_patent_app_number] => 12573489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778148 [patent_doc_number] => 20120040851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'miRNA TARGETS' [patent_app_type] => utility [patent_app_number] => 13/063156 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 79 [patent_figures_cnt] => 79 [patent_no_of_words] => 25697 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040851.pdf [firstpage_image] =>[orig_patent_app_number] => 13063156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6162754 [patent_doc_number] => 20110160085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'BIOMARKERS FOR ANTI-TNF TREATMENT IN ULCREATIVE COLITIS AND RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/056741 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12830 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160085.pdf [firstpage_image] =>[orig_patent_app_number] => 13056741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9937131 [patent_doc_number] => 08986935 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Methods for treating spinal muscular atrophy' [patent_app_type] => utility [patent_app_number] => 13/058653 [patent_app_country] => US [patent_app_date] => 2009-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 65339 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 419 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13058653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937695 [patent_doc_number] => 20110213005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'METHODS FOR TREATING VIRAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/058613 [patent_app_country] => US [patent_app_date] => 2009-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 69981 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213005.pdf [firstpage_image] =>[orig_patent_app_number] => 13058613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6417575 [patent_doc_number] => 20100167291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'ASSESSING EXPRESSION OF ENDOGENOUS AND EXOGENOUS GENES' [patent_app_type] => utility [patent_app_number] => 12/539436 [patent_app_country] => US [patent_app_date] => 2009-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10657 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167291.pdf [firstpage_image] =>[orig_patent_app_number] => 12539436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6594946 [patent_doc_number] => 20100062442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'CELL DETECTION' [patent_app_type] => utility [patent_app_number] => 12/537181 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17163 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062442.pdf [firstpage_image] =>[orig_patent_app_number] => 12537181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6162766 [patent_doc_number] => 20110160086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'GENE EXPRESSION SIGNATURE FOR CLASSIFICATION OF KIDNEY TUMORS' [patent_app_type] => utility [patent_app_number] => 13/057750 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20939 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160086.pdf [firstpage_image] =>[orig_patent_app_number] => 13057750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446878 [patent_doc_number] => 20100105046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'METHODS OF DIAGNOSING CARDIOVASCULAR DISEASE' [patent_app_type] => utility [patent_app_number] => 12/535614 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9718 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105046.pdf [firstpage_image] =>[orig_patent_app_number] => 12535614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313594 [patent_doc_number] => 20120190562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'METHODS AND COMPOSITIONS FOR DETERMINING SEVERITY OF HEART FAILURE IN A SUBJECT' [patent_app_type] => utility [patent_app_number] => 13/056282 [patent_app_country] => US [patent_app_date] => 2009-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 127149 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13056282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148772 [patent_doc_number] => 20110020367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Methods of Evaluating Transplant Rejection' [patent_app_type] => utility [patent_app_number] => 12/510966 [patent_app_country] => US [patent_app_date] => 2009-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26411 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020367.pdf [firstpage_image] =>[orig_patent_app_number] => 12510966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670011 [patent_doc_number] => 20110319280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'ECT2 ONCOGENE AS A THERAPEUTIC TARGET AND PROGNOSTIC INDICATOR FOR LUNG AND ESOPHAGEAL CANCER' [patent_app_type] => utility [patent_app_number] => 13/002977 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22802 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13002977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6622571 [patent_doc_number] => 20100003690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'COMPOSITIONS AND METHODS FOR DISCOVERING AGENTS FOR PHARMACOLOGICAL RESCUE OF HERG 1B SUBUNITS FOR THE TREATMENT OF LONG QT SYNDROME' [patent_app_type] => utility [patent_app_number] => 12/490987 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7690 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003690.pdf [firstpage_image] =>[orig_patent_app_number] => 12490987 [rel_patent_id] =>[rel_patent_doc_number] =>)